Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Gross Profit (2016 - 2025)

Historic Gross Profit for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.1 million.

  • Jaguar Health's Gross Profit fell 109.29% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 4680.26%. This contributed to the annual value of $4.0 million for FY2024, which is 2108.45% up from last year.
  • Jaguar Health's Gross Profit amounted to $1.1 million in Q3 2025, which was down 109.29% from $512000.0 recorded in Q2 2025.
  • Jaguar Health's Gross Profit's 5-year high stood at $1.5 million during Q4 2022, with a 5-year trough of -$1.8 million in Q2 2021.
  • Moreover, its 5-year median value for Gross Profit was $777000.0 (2022), whereas its average is $378105.3.
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 23110.93% in 2021, then surged by 93181.82% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Gross Profit stood at -$218000.0 in 2021, then soared by 793.58% to $1.5 million in 2022, then crashed by 49.14% to $769000.0 in 2023, then grew by 3.25% to $794000.0 in 2024, then surged by 36.78% to $1.1 million in 2025.
  • Its Gross Profit was $1.1 million in Q3 2025, compared to $512000.0 in Q2 2025 and -$279000.0 in Q1 2025.